You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-CYLD (CYLD) Antibodies

Full name:
anti-Cylindromatosis (Turban Tumor Syndrome) Antibodies (CYLD)
On www.antibodies-online.com are 68 Cylindromatosis (Turban Tumor Syndrome) (CYLD) Antibodies from 17 different suppliers available. Additionally we are shipping CYLD Proteins (7) and CYLD Kits (6) and many more products for this protein. A total of 85 CYLD products are currently listed.
Synonyms:
2010013M14Rik, 2900009M21Rik, BRSS, C130039D01Rik, CDMT, cyld, CYLD1, CYLDI, EAC, LRRGT00003, MFT, MFT1, mKIAA0849, Rp1, Rp1h, SBS, TEM, USPL2
list all antibodies Gene Name GeneID UniProt
CYLD 100362727  
CYLD 74256 Q80TQ2
CYLD 1540 Q9NQC7

Show all species

Show all synonyms

Most Popular Reactivities for anti-CYLD (CYLD) Antibodies

Select your species and application

anti-Rat (Rattus) CYLD Antibodies:

anti-Mouse (Murine) CYLD Antibodies:

anti-Human CYLD Antibodies:

All available anti-CYLD Antibodies

Go to our pre-filtered search.

Top referenced anti-CYLD Antibodies

  1. Mouse (Murine) Polyclonal CYLD Primary Antibody for WB - ABIN374832 : Massoumi, Chmielarska, Hennecke, Pfeifer, Fässler: Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. in Cell 2006 (PubMed)

More Antibodies against CYLD Interaction Partners

Zebrafish Cylindromatosis (Turban Tumor Syndrome) (CYLD) interaction partners

  1. The crystal structures representing the catalytic states of zebrafish CYLD for Met1 (show DNMT1 Antibodies)- and Lys63-linked Ub chains and two distinct precatalytic states for Met1 (show DNMT1 Antibodies)-linked chains are presented.

Mouse (Murine) Cylindromatosis (Turban Tumor Syndrome) (CYLD) interaction partners

  1. Deubiquitinase CYLD negatively regulates MyD88 (show MYD88 Antibodies)-mediated signaling by directly interacting with MyD88 (show MYD88 Antibodies) and deubiquitinating nontypeable Haemophilus influenzae (NTHi)-induced K63-linked polyubiquitination of MyD88 (show MYD88 Antibodies) at lysine 231.

  2. CYLD interrupts the ERK (show EPHB2 Antibodies)- and p38 (show CRK Antibodies)-/AP-1 (show JUN Antibodies) and c-Myc (show MYC Antibodies) pathways to suppress Nrf2 (show NFE2L2 Antibodies)-operated antioxidative capacity, thereby enhancing oxidative stress in the heart.

  3. Our data demonstrate that inefficient negative selection in the thymus of CYLD(ex7/8) mice result from a defect in mTEC maturation.

  4. The deubiquitinating enzyme CYLD controls apical docking of basal bodies in ciliated epithelial cells.

  5. Data show that the in utero death of NF-NF (show NFASC Antibodies)-kappaB (show NFKB1 Antibodies) essential modulator (NEMO (show IKBKG Antibodies)) and cylindromatosis protein double mutant mice is mediated by TNF (show TNF Antibodies) receptor 1 (TNFR1 (show TNFRSF1A Antibodies)) signaling and can be rescued by TNFR1 (show TNFRSF1A Antibodies) deficiency.

  6. CYLD is a central regulator of apoptotic cell death in murine hepatocytes by controlling NF-kappaB (show NFKB1 Antibodies) dependent anti-apoptotic signaling.

  7. In contrast to full-length CYLD, the immune function of short splice variant CYLD (sCYLD) is insufficiently described. To explore sCYLD's function in infection, investigated whether dendritic cell-specific sCYLD regulates the pathogenesis of listeriosis.

  8. The ciliary function of CYLD is partially attributed to its deconjugation of the polyubiquitin (show UBB Antibodies) chain from centrosomal protein of 70 kDa (Cep70 (show CEP70 Antibodies)), a requirement for Cep70 (show CEP70 Antibodies) to interact with gamma-tubulin (show TUBG1 Antibodies) and localize at the centrosome.

  9. CYLD negatively regulates nontypeable Haemophilus influenzae-induced IL-8 (show IL8 Antibodies) expression via MKP-1 (show DUSP1 Antibodies)-dependent inhibition of ERK (show EPHB2 Antibodies).

  10. identifying the CYLD-TRAF2 (show TRAF2 Antibodies)-p38MAPK (show MAPK14 Antibodies) pathway as a novel important regulator of HSC (show FUT1 Antibodies) function restricting HSC (show FUT1 Antibodies) cycling and promoting dormancy.

Human Cylindromatosis (Turban Tumor Syndrome) (CYLD) interaction partners

  1. Haplotype analysis was performed for the patients with multiple familial trichoepithelioma type 1, patients with familial cylindromatosis and a patient with Brooke-Spiegler syndrome, all of whom carry the same heterozygous nonsense CYLD mutation.

  2. Ultraviolet radiation induced CYLD translocation from the cytoplasm to microtubules, posttranslational modification and degradation in a proteasome-independent manner.

  3. Deubiquitinase CYLD negatively regulates MyD88 (show MYD88 Antibodies)-mediated signaling by directly interacting with MyD88 (show MYD88 Antibodies) and deubiquitinating nontypeable Haemophilus influenzae (NTHi)-induced K63-linked polyubiquitination of MyD88 (show MYD88 Antibodies) at lysine 231.

  4. CYLD interrupts the ERK (show EPHB2 Antibodies)- and p38 (show CRK Antibodies)-/AP-1 (show FOSB Antibodies) and c-Myc (show MYC Antibodies) pathways to suppress Nrf2 (show GABPA Antibodies)-operated antioxidative capacity, thereby enhancing oxidative stress in the heart.

  5. Data suggest OPTN (optineurin (show OPTN Antibodies)) is involved in up-regulation of innate immunity in mitosis; mechanism involves phosphorylation/nuclear translocation of CYLD and phosphorylation/mitochondrial translocation of TBK1 (NF-kB-activating kinase (show TBK1 Antibodies)).

  6. CaMKII (show CAMK2G Antibodies)-mediated recruitment and upregulation of CYLD is expected to remove K63-linked polyubiquitins and facilitate proteasomal degradation at the postsynaptic density.

  7. The deubiquitinating enzyme CYLD controls apical docking of basal bodies in ciliated epithelial cells.

  8. Phenotype-genotype correlations for clinical variants caused by CYLD mutations. [Review]

  9. we identified a novel mutation of the CYLD gene in a Chinese multiple familial trichoepithelioma family.

  10. Low CYLD expression is associated with colorectal cancer.

CYLD Antigen Profile

Antigen Summary

This gene is encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.

Alternative names and synonyms associated with CYLD

  • cylindromatosis (turban tumor syndrome) (CYLD) antibody
  • cylindromatosis (turban tumor syndrome), a (cylda) antibody
  • ubiquitin carboxyl-terminal hydrolase CYLD (LOC100362727) antibody
  • cylindromatosis (turban tumor syndrome) (Cyld) antibody
  • 2010013M14Rik antibody
  • 2900009M21Rik antibody
  • BRSS antibody
  • C130039D01Rik antibody
  • CDMT antibody
  • cyld antibody
  • CYLD1 antibody
  • CYLDI antibody
  • EAC antibody
  • LRRGT00003 antibody
  • MFT antibody
  • MFT1 antibody
  • mKIAA0849 antibody
  • Rp1 antibody
  • Rp1h antibody
  • SBS antibody
  • TEM antibody
  • USPL2 antibody

Protein level used designations for CYLD

cylindromatosis (turban tumor syndrome) , probable ubiquitin carboxyl-terminal hydrolase CYLD-like , ubiquitin carboxyl-terminal hydrolase CYLD , deubiquitinating enzyme CYLD , ubiquitin thioesterase CYLD , ubiquitin thiolesterase CYLD , ubiquitin-specific-processing protease CYLD , probable ubiquitin carboxyl-terminal hydrolase CYLD , retinitis pigmentosa 1 homolog , ubiquitin specific peptidase like 2

GENE ID SPECIES
100050308 Equus caballus
556823 Danio rerio
100467467 Ailuropoda melanoleuca
100547998 Meleagris gallopavo
100362727 Rattus norvegicus
74256 Mus musculus
312937 Rattus norvegicus
1540 Homo sapiens
611649 Canis lupus familiaris
536421 Bos taurus
415725 Gallus gallus
Selected quality suppliers for anti-CYLD (CYLD) Antibodies
Did you look for something else?